Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,556 | 21,568 | 16,292 | 27,298 | 33,362 |
| Receivables | 1,066 | 374 | 1,081 | 1,106 | 893 |
| TOTAL | $48,656 | $23,795 | $19,069 | $29,400 | $35,326 |
| Non-Current Assets | |||||
| PPE Net | 14,600 | 12,973 | 11,045 | 7,043 | 4,449 |
| Investments And Advances | 269 | 269 | 269 | 269 | 509 |
| Intangibles | 19,709 | 20,099 | 20,523 | 20,939 | 21,357 |
| Other Non-Current Assets | 3,492 | 4,026 | 2,721 | 2,226 | 1,950 |
| TOTAL | $38,070 | $37,368 | $34,558 | $30,478 | $28,265 |
| Total Assets | $86,726 | $61,162 | $53,627 | $59,877 | $63,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 332 | 225 | 1,236 | 1,169 | 783 |
| Accrued Expenses | 1,856 | 1,097 | 729 | 593 | 326 |
| Other current liabilities | 2,987 | 2,325 | 1,358 | 1,660 | 866 |
| TOTAL | $5,205 | $3,676 | $3,862 | $4,520 | $2,006 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 510 | 1,070 | N/A |
| Other Non-Current Liabilities | 199 | 184 | 0 | 0 | 362 |
| TOTAL | $199 | $184 | $N/A | $N/A | $362 |
| Total Liabilities | $5,404 | $3,860 | $3,862 | $4,520 | $2,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,006 | 17,004 | 14,010 | 14,109 | 14,291 |
| Common Shares | 18 | 16 | 14 | 14 | 14 |
| Retained earnings | -119,533 | -111,037 | -104,114 | -97,912 | -91,709 |
| Other shareholders' equity | 735 | -367 | -1,162 | -1,368 | -1,063 |
| TOTAL | $81,322 | $57,303 | $49,764 | $55,357 | $61,223 |
| Total Liabilities And Equity | $86,726 | $61,162 | $53,627 | $59,878 | $63,591 |